Projects funded by the NCN

Proteomic characterization, transcriptional and epigenetic regulation of drugtransporters in colorectal cancer

Call: PRELUDIUM 24 , Panel: NZ7

Principal investigator: Nina Ewa Komaniecka

Pomorski Uniwersytet Medyczny w Szczecinie

The role of EZH2 activity in the development of resistance to targeted therapy in melanoma

Call: OPUS 28 , Panel: NZ7

Principal investigator: dr Michał Jerzy Woźniak

Uniwersytet Medyczny w Łodzi

M6A RNA methylation signatures as a targets for HPV-dependent HNSCC therapy

Call: OPUS 27 , Panel: NZ5

Principal investigator: Kamila Ostrowska

Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu

Semaglutide and neurodevelopment: investigating risks arising from prenatal exposure to a widely popular drug for diabet...

Call: OPUS 26 , Panel: NZ7

Principal investigator: dr Agnieszka Wnuk

Instytut Farmakologii PAN

Deciphering the Chemoproteomics and Chemotranscriptomics of Anti-Alzheimer Drugs for Novel Druggable Target Identificati...

Call: JPND Call 2023 , Panel: NZ5

Principal investigator: prof. Krzysztof Sobczak

Uniwersytet im. Adama Mickiewicza w Poznaniu, Wydział Biologii

Structure-guided design of histone demethylase inhibitors for cancer therapy.

Call: SONATA 17 , Panel: NZ7

Principal investigator: dr Piotr Henryk Małecki

Instytut Chemii Bioorganicznej PAN

Drug metabolizing enzymes (DMEs) in liver pathology, proteomic characteristics, transcriptional and epigenetic regulatio...

Call: OPUS 19 , Panel: NZ7

Principal investigator: prof. Marek Droździk

Pomorski Uniwersytet Medyczny w Szczecinie

Searching for behavioural and molecular predictors of long-term benzodiazepine administration in preclinical chronic str...

Call: SONATINA 2 , Panel: NZ7

Principal investigator: dr Karolina Anna Kołosowska

Instytut Psychiatrii i Neurologii

Identification of epigenetic mechanisms contributing to glioma drug resistance

Call: POLONEZ 3 , Panel: NZ2

Principal investigator: dr Jakub Karol Mieczkowski

Instytut Biologii Doświadczalnej im. M. Nenckiego PAN

The role of DNA methylation in enhancing the sensitivity of colorectal cancer cells to topoisomerase inhibitors.

Call: PRELUDIUM 9 , Panel: NZ3

Principal investigator: Alicja Patrycja Pawlak

Instytut Immunologii i Terapii Doświadczalnej im. Ludwika Hirszfelda Polskiej Akademii Nauk

Identification of new, clinically relevant genetic and epigenetic aberrations by next-generation sequencing in chronic m...

Call: HARMONIA 6 , Panel: NZ5

Principal investigator: dr Tomasz Artur Stokłosa

Warszawski Uniwersytet Medyczny, Wydział Lekarski

Molecular mechanism of epigenetic drugs action to prevent multi-organ injury in a mouse model of sepsis

Call: HARMONIA 6 , Panel: NZ5

Principal investigator: dr Michał Marek Mikula

Centrum Onkologii - Instytut im. Marii Skłodowskiej-Curie